The US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding the company’s syndromic testing offerings in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback